133 related articles for article (PubMed ID: 35261045)
1. Distant metastasis in medullary thyroid carcinoma: Clinical outcomes and implications of T stage.
Shao Y; Li G; Wei T; Gong R; Li Z; Zhu J; Lei J
Clin Endocrinol (Oxf); 2022 Nov; 97(5):676-684. PubMed ID: 35261045
[TBL] [Abstract][Full Text] [Related]
2. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
[No Abstract] [Full Text] [Related]
3. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
6. Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications.
Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
Clin Endocrinol (Oxf); 2022 Sep; 97(3):355-362. PubMed ID: 35192214
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and optimal cutoff of age in medullary thyroid cancer.
Qu N; Shi RL; Luo TX; Wang YL; Li DS; Wang Y; Huang CP; Ji QH
Oncotarget; 2016 Mar; 7(13):15937-47. PubMed ID: 26910117
[TBL] [Abstract][Full Text] [Related]
8. Effects of marital status on survival of medullary thyroid cancer stratified by age.
Ai L; Li N; Tan HL; Wei B; Zhao YX; Chen P; Hu HY; Liu M; Ou-Yang DJ; Qin ZE; Huang P; Chang S
Cancer Med; 2021 Dec; 10(24):8829-8837. PubMed ID: 34723436
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract][Full Text] [Related]
10. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
de Vries LH; Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJM; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
Endocrine; 2018 Dec; 62(3):639-647. PubMed ID: 30128959
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.
Wu X; Li B; Zheng C
Technol Cancer Res Treat; 2022; 21():15330338221078435. PubMed ID: 35188853
[No Abstract] [Full Text] [Related]
13. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
[No Abstract] [Full Text] [Related]
14. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
15. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program.
Zhao Z; Yin XD; Zhang XH; Li ZW; Wang DW
Sci Rep; 2020 Aug; 10(1):13310. PubMed ID: 32764626
[TBL] [Abstract][Full Text] [Related]
17. New proposed tumor-node-metastasis staging system for medullary thyroid carcinoma based on the Surveillance, Epidemiology, and End Results database.
Wang M; Hu D; Zeng W; Chen S; Huang Y; Zhou L; Zhou W; Wei W; Zhang C; Liu Z; Guo L
Am J Transl Res; 2020; 12(6):2703-2710. PubMed ID: 32655802
[TBL] [Abstract][Full Text] [Related]
18. Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.
Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
[TBL] [Abstract][Full Text] [Related]
19. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
[No Abstract] [Full Text] [Related]
20. Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis.
Huang S; Zhong J; Zhang Z; Chen R; Li J; Sun J; Chen H
Transl Cancer Res; 2021 Nov; 10(11):4714-4726. PubMed ID: 35116326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]